Cardio metabolic risk factors for atrial fibrillation in type 2 diabetes mellitus: Focus on hypertension, metabolic syndrome and obesity

Objective. Atrial fibrillation (AF) in type 2 diabetes mellitus (T2DM) has been little explored so far. However, there are several cardio metabolic risk factors for AF in T2DM patients, such as arterial hypertension, obesity or the metabolic syndrome. Our objective was to evaluate cardio metabolic r...

Full description

Bibliographic Details
Main Authors: Mihnea A. Găman, Elena C. Dobrică, Emilia G. Pascu, Matei A. Cozma, Mirela E. Epîngeac, Amelia M. Găman, Anca P. Stoian, Ovidiu G. Bratu, Camelia C. Diaconu
Format: Article
Language:English
Published: Ion Motofei, Carol Davila University 2019-05-01
Series:Journal of Mind and Medical Sciences
Subjects:
Online Access:https://scholar.valpo.edu/cgi/viewcontent.cgi?article=1178&context=jmms
id doaj-152edd6967604c4e9de63348d49fe1c1
record_format Article
spelling doaj-152edd6967604c4e9de63348d49fe1c12020-11-25T01:35:18ZengIon Motofei, Carol Davila UniversityJournal of Mind and Medical Sciences2392-76742019-05-016115716110.22543/7674.61.P157161Cardio metabolic risk factors for atrial fibrillation in type 2 diabetes mellitus: Focus on hypertension, metabolic syndrome and obesityMihnea A. GămanElena C. DobricăEmilia G. PascuMatei A. CozmaMirela E. EpîngeacAmelia M. GămanAnca P. StoianOvidiu G. BratuCamelia C. DiaconuObjective. Atrial fibrillation (AF) in type 2 diabetes mellitus (T2DM) has been little explored so far. However, there are several cardio metabolic risk factors for AF in T2DM patients, such as arterial hypertension, obesity or the metabolic syndrome. Our objective was to evaluate cardio metabolic risk factors for AF in T2DM patients. Methods. We studied the medical records of T2DM patients hospitalized in the Internal Medicine department of an emergency referral hospital in Bucharest, Romania. The study was observational, retrospective and carried out between January-June 2018. Results. The study group included 221 T2DM patients (with a mean age of 68.65 ± 10.64, ranging between 37-93 years): 116 women (52.49%; with a mean age of 70.53 ± 10.69, ranging between 37-93 years) and 105 men (47.51%; with a mean age of 66.57 ± 10.23, ranging between 38-91 years). 92 patients had AF (41.63%): 40 women (34.48%) and 52 men (49.52%). 180 patients (81.45%) were hypertensive: 103 women (88.79%) and 77 men (73.33%). 113 patients (51.13%) had metabolic syndrome: 58 women (50.00%) and 55 men (52.38%). 77 patients (34.84%) were obese: 45 women (38.79%) and 32 men (30.48%). AF patients associated obesity in 26 cases (28.26%), hypertension in 73 cases (79.35%) and metabolic syndrome in 56 cases (60.87%). Conclusions. Out of the study group, 92 T2DM patients (41.63%) had AF, men being more likely to suffer from AF than women (p=0.0288). Hypertension affected 180 patients (81.45%) and in greater proportion women vs. men (p=0.0051). The metabolic syndrome and obesity were discovered in 113 patients (51.13%) and 77 patients (34.84%), respectively, with no significant differences in terms of gender. In our research, the highest cardio metabolic risk factors for AF in T2DM were hypertension (OR = 3.6675) and the metabolic syndrome (OR = 3.3388).https://scholar.valpo.edu/cgi/viewcontent.cgi?article=1178&context=jmmsdiabetes mellitusatrial fibrillationhypertensionobesitymetabolic syndromerisk factors
collection DOAJ
language English
format Article
sources DOAJ
author Mihnea A. Găman
Elena C. Dobrică
Emilia G. Pascu
Matei A. Cozma
Mirela E. Epîngeac
Amelia M. Găman
Anca P. Stoian
Ovidiu G. Bratu
Camelia C. Diaconu
spellingShingle Mihnea A. Găman
Elena C. Dobrică
Emilia G. Pascu
Matei A. Cozma
Mirela E. Epîngeac
Amelia M. Găman
Anca P. Stoian
Ovidiu G. Bratu
Camelia C. Diaconu
Cardio metabolic risk factors for atrial fibrillation in type 2 diabetes mellitus: Focus on hypertension, metabolic syndrome and obesity
Journal of Mind and Medical Sciences
diabetes mellitus
atrial fibrillation
hypertension
obesity
metabolic syndrome
risk factors
author_facet Mihnea A. Găman
Elena C. Dobrică
Emilia G. Pascu
Matei A. Cozma
Mirela E. Epîngeac
Amelia M. Găman
Anca P. Stoian
Ovidiu G. Bratu
Camelia C. Diaconu
author_sort Mihnea A. Găman
title Cardio metabolic risk factors for atrial fibrillation in type 2 diabetes mellitus: Focus on hypertension, metabolic syndrome and obesity
title_short Cardio metabolic risk factors for atrial fibrillation in type 2 diabetes mellitus: Focus on hypertension, metabolic syndrome and obesity
title_full Cardio metabolic risk factors for atrial fibrillation in type 2 diabetes mellitus: Focus on hypertension, metabolic syndrome and obesity
title_fullStr Cardio metabolic risk factors for atrial fibrillation in type 2 diabetes mellitus: Focus on hypertension, metabolic syndrome and obesity
title_full_unstemmed Cardio metabolic risk factors for atrial fibrillation in type 2 diabetes mellitus: Focus on hypertension, metabolic syndrome and obesity
title_sort cardio metabolic risk factors for atrial fibrillation in type 2 diabetes mellitus: focus on hypertension, metabolic syndrome and obesity
publisher Ion Motofei, Carol Davila University
series Journal of Mind and Medical Sciences
issn 2392-7674
publishDate 2019-05-01
description Objective. Atrial fibrillation (AF) in type 2 diabetes mellitus (T2DM) has been little explored so far. However, there are several cardio metabolic risk factors for AF in T2DM patients, such as arterial hypertension, obesity or the metabolic syndrome. Our objective was to evaluate cardio metabolic risk factors for AF in T2DM patients. Methods. We studied the medical records of T2DM patients hospitalized in the Internal Medicine department of an emergency referral hospital in Bucharest, Romania. The study was observational, retrospective and carried out between January-June 2018. Results. The study group included 221 T2DM patients (with a mean age of 68.65 ± 10.64, ranging between 37-93 years): 116 women (52.49%; with a mean age of 70.53 ± 10.69, ranging between 37-93 years) and 105 men (47.51%; with a mean age of 66.57 ± 10.23, ranging between 38-91 years). 92 patients had AF (41.63%): 40 women (34.48%) and 52 men (49.52%). 180 patients (81.45%) were hypertensive: 103 women (88.79%) and 77 men (73.33%). 113 patients (51.13%) had metabolic syndrome: 58 women (50.00%) and 55 men (52.38%). 77 patients (34.84%) were obese: 45 women (38.79%) and 32 men (30.48%). AF patients associated obesity in 26 cases (28.26%), hypertension in 73 cases (79.35%) and metabolic syndrome in 56 cases (60.87%). Conclusions. Out of the study group, 92 T2DM patients (41.63%) had AF, men being more likely to suffer from AF than women (p=0.0288). Hypertension affected 180 patients (81.45%) and in greater proportion women vs. men (p=0.0051). The metabolic syndrome and obesity were discovered in 113 patients (51.13%) and 77 patients (34.84%), respectively, with no significant differences in terms of gender. In our research, the highest cardio metabolic risk factors for AF in T2DM were hypertension (OR = 3.6675) and the metabolic syndrome (OR = 3.3388).
topic diabetes mellitus
atrial fibrillation
hypertension
obesity
metabolic syndrome
risk factors
url https://scholar.valpo.edu/cgi/viewcontent.cgi?article=1178&context=jmms
work_keys_str_mv AT mihneaagaman cardiometabolicriskfactorsforatrialfibrillationintype2diabetesmellitusfocusonhypertensionmetabolicsyndromeandobesity
AT elenacdobrica cardiometabolicriskfactorsforatrialfibrillationintype2diabetesmellitusfocusonhypertensionmetabolicsyndromeandobesity
AT emiliagpascu cardiometabolicriskfactorsforatrialfibrillationintype2diabetesmellitusfocusonhypertensionmetabolicsyndromeandobesity
AT mateiacozma cardiometabolicriskfactorsforatrialfibrillationintype2diabetesmellitusfocusonhypertensionmetabolicsyndromeandobesity
AT mirelaeepingeac cardiometabolicriskfactorsforatrialfibrillationintype2diabetesmellitusfocusonhypertensionmetabolicsyndromeandobesity
AT ameliamgaman cardiometabolicriskfactorsforatrialfibrillationintype2diabetesmellitusfocusonhypertensionmetabolicsyndromeandobesity
AT ancapstoian cardiometabolicriskfactorsforatrialfibrillationintype2diabetesmellitusfocusonhypertensionmetabolicsyndromeandobesity
AT ovidiugbratu cardiometabolicriskfactorsforatrialfibrillationintype2diabetesmellitusfocusonhypertensionmetabolicsyndromeandobesity
AT cameliacdiaconu cardiometabolicriskfactorsforatrialfibrillationintype2diabetesmellitusfocusonhypertensionmetabolicsyndromeandobesity
_version_ 1725067170269888512